- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07375459
Community-based Mobile-assisted Brief Intervention for Smoking Cessation
July 15, 2026 updated by: LUK Tzu Tsun, National University of Singapore
Mobile-assisted Brief Intervention for Smoking Cessation in Community-based Setting: a Pilot Randomised Controlled Trial
The goal of this pilot trial is to evaluate the feasibility of a mobile-assisted brief intervention for smoking cessation in community-based individuals in Singapore. Specific aims include:
- To assess how many eligible individuals accept the invitation to participate in the trial
- To assess the retention of the participants through 6 months after treatment initiation
- To assess the acceptability of the intervention in terms of participants' engagement and ratings
- To examine the intervention effect on abstinence outcomes
Participants will be randomly assigned to either the intervention group or control group and followed for 6 months from randomisation.
Study Overview
Status
Active, not recruiting
Conditions
Study Type
Interventional
Enrollment (Estimated)
100
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Singapore, Singapore
- National University of Singapore
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Aged 21 to 80 years
- Smoked at least one cigarette daily
- Able to communicate and read in English or Chinese
- Own a smartphone with WhatsApp installed
Exclusion Criteria:
- Exposed to any smoking cessation treatment in the past 3 months
- Pregnant women
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Mobile-assisted brief intervention
|
Participants will receive brief cessation advice following the AWARD (ask, warn, advise, refer, do-it-again) model and a 24-page self-help booklet.
Research personnel will assist the participant in signing up for the I Quit Programme to receive additional cessation support, unless they decline
Participants will receive personalised chat-based support delivered by a live counsellor for 3 months via WhatsApp.
The message will incorporate behaviour change techniques for smoking cessation and mindfulness principles to strengthen participants' capacity to quit smoking.
|
|
Active Comparator: Brief advice
|
Participants will receive brief cessation advice following the AWARD (ask, warn, advise, refer, do-it-again) model and a 24-page self-help booklet.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Retention rate
Time Frame: 6 months
|
Number of participants completed the follow-up divided by the number of participants
|
6 months
|
|
Recruitment rate
Time Frame: 6 months
|
Number of participants divided by the number of eligible subjects
|
6 months
|
|
Biochemically validated smoking abstinence rate
Time Frame: 6 months
|
Defined as an exhaled carbon monoxide level of <5 parts per million or a negative salivary cotinine test (cut off 30ng/mL)
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Self-reported 7-day point-prevalence smoking abstinence rate
Time Frame: 3 months
|
Being completely smoke-free in the past 7 days
|
3 months
|
|
Self-reported 7-day point-prevalence smoking abstinence rate
Time Frame: 6 months
|
Being completely smoke-free in the past 7 days
|
6 months
|
|
Self-reported smoking reduction rate
Time Frame: 3 months
|
Smoking reduction by at least half of the baseline daily number of cigarettes in individuals who continue to smoke
|
3 months
|
|
Self-reported smoking reduction rate
Time Frame: 6 months
|
Smoking reduction by at least half of the baseline daily number of cigarettes in individuals who continue to smoke
|
6 months
|
|
Self-reported quit attempt rate
Time Frame: 3 months
|
Serious quit attempt that lasted 24 hours or longer
|
3 months
|
|
Self-reported quit attempt rate
Time Frame: 6 months
|
Serious quit attempt that lasted 24 hours or longer
|
6 months
|
|
Smoking cessation service use rate
Time Frame: 3 months
|
Use of any smoking cessation service during the follow-up period
|
3 months
|
|
Smoking cessation service use rate
Time Frame: 6 months
|
Use of any smoking cessation service during the follow-up period
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Tzu Tsun Luk, PhD, RN, National University of Singapore
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 4, 2026
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
March 31, 2027
Study Registration Dates
First Submitted
January 22, 2026
First Submitted That Met QC Criteria
January 22, 2026
First Posted (Actual)
January 29, 2026
Study Record Updates
Last Update Posted (Actual)
July 16, 2026
Last Update Submitted That Met QC Criteria
July 15, 2026
Last Verified
July 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- NUS-IRB-2025-690
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.